Education
About Us
Working with TipRanks
Follow Us
Masimo Corp (MASI)
NASDAQ:MASI
MASI Stock Chart & Stats
$142.05
$0.33(0.20%)
At close: 4:00 PM EST
$142.05
$0.33(0.20%)
Day’s Range― - ―
52-Week Range$125.94 - $194.88
Previous CloseN/A
Volume102.94K
Average Volume (3M)705.65K
Market Cap
$7.63B
Enterprise Value$7.96B
Total Cash (Recent Filing)$314.70M
Total Debt (Recent Filing)$586.20M
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Mar 03, 2026EPS Estimate
1.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.32
Shares Outstanding53,713,947
10 Day Avg. Volume761,858
30 Day Avg. Volume705,649
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)8.66
Price to Sales (P/S)4.35
P/FCF Ratio51.66
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue4.64
Enterprise Value/Gross Profit8.45
Enterprise Value/Ebitda-111.85
Forecast
1Y Price Target
$188.40Price Target Upside32.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)5.89
Revenue Forecast (FY)$1.62B
Bulls Say, Bears Say
Bulls Say
Earnings Beats And DemandRevenue, adjusted earnings and product shipments exceeded analyst consensus, signaling stronger demand and operational execution that could support upside to estimates.
Product Innovation And DifferentiationIntroduction of new pulse-ox sensors with capabilities to detect opioid-induced respiratory depression and atrial fibrillation offers unique clinical functionality not matched by competitors and may drive adoption and share gains.
Recurring Revenue And Faster Innovation CycleA high proportion of recurring revenue combined with a quicker, software-driven innovation cycle supports more predictable cash flow and a expanding pipeline of monitoring products.
Bears Say
Litigation Timeline RiskAn expected Apple appeal could delay collection of awarded damages and extend legal uncertainty, leaving the timing of cash realization unclear for investors.
Reimbursement, Tariff And Cost RisksPotential reimbursement cuts, tariffs, cost inflation and commercial disruptions from territory or leadership changes could lower utilization and compress margins, posing downside risk to earnings.
Valuation PressureCurrent valuation appears to embed much of the anticipated margin upside, which limits upside potential and has prompted some analysts to maintain a Hold rating.
Masimo News
MASI FAQ
What was Masimo Corp’s price range in the past 12 months?
Masimo Corp lowest stock price was $125.94 and its highest was $194.88 in the past 12 months.
What is Masimo Corp’s market cap?
Masimo Corp’s market cap is $7.63B.
When is Masimo Corp’s upcoming earnings report date?
Masimo Corp’s upcoming earnings report date is Mar 03, 2026 which is in 43 days.
How were Masimo Corp’s earnings last quarter?
Masimo Corp released its earnings results on Nov 04, 2025. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.214 by $0.106.
Is Masimo Corp overvalued?
According to Wall Street analysts Masimo Corp’s price is currently Undervalued.
Does Masimo Corp pay dividends?
Masimo Corp pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on Masimo Corp dividends here
What is Masimo Corp’s EPS estimate?
Masimo Corp’s EPS estimate is 1.46.
How many shares outstanding does Masimo Corp have?
Masimo Corp has 53,713,947 shares outstanding.
What happened to Masimo Corp’s price movement after its last earnings report?
Masimo Corp reported an EPS of $1.32 in its last earnings report, beating expectations of $1.214. Following the earnings report the stock price went down -4.61%.
Which hedge fund is a major shareholder of Masimo Corp?
Currently, no hedge funds are holding shares in MASI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Masimo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$188.40 (32.63% Upside)
$188.40 (32.63% Upside)
Blogger Sentiment
Bullish
MASI Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 127.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.8%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.41%
12-Months-Change
Fundamentals
Return on Equity
-17.93%
Trailing 12-Months
Asset Growth
-41.14%
Trailing 12-Months
Company Description
Masimo Corp
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
MASI Company Deck
MASI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Masimo delivered strong financial performance with significant revenue growth, operating margin expansion, and increased EPS. Strategic partnerships and shareholder returns were also notable achievements. However, challenges such as a decline in gross margin due to tariffs, and lower-than-expected consumables growth, along with tightened revenue guidance, presented some concerns.View all MASI earnings summariesMASI Stock 12 Month Forecast
Average Price Target
$188.40
▲(32.63% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---